← Eichor
Study identifier: NCT05806021 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis

Condition: Primary Gonarthrosis  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhasePhase 4
Planned participants327
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

Osteoarthritis of the knee is a common problem that is increasing in prevalence as the population ages. In a knee with osteoarthritis, there is variable damage to the articular cartilage and underlying bone that can cause varying degrees of pain. When pain is bothersome, osteoarthritis is treated to improve functional abilities. One of the most recognized and used treatments is intra-articular cortisone injection. Cortisone is a powerful anti-inflammatory drug that is used to reduce pain. Unfortunately, cortisone can have significant side effects, even when injected locally. The frequency and intensity of these side effects depend largely on the total dose injected. The main side effects include increased blood sugar levels, increased blood pressure and a temporary decrease in the secretion of the stress hormone, cortisol. In the long term, a decrease in articular cartilage thickness in the injected join and overall bone density reduction is also reported. Despite many years of routine use, the smallest effective dose of cortisone injected into the knee joint is unknown. The main objective of the study is to determine the impact on pain and function of different doses of cortisone injected into the knee. The cortisone chosen for this study is triamcinolone acetonide (TA).

This description comes directly from the study's public registry record.

Talk to the study team

Dien Hung Luong, MD  ·  5148908000  ·  dh.luong79@gmail.com

Mathieu Boudier-Revéret, MD  ·  5148908000  ·  mathieu.boudier-reveret.med@ssss.gouv.qc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier Universitaire de Montréal - Hôtel-DieuMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05806021